Ipsen S.A. (IPSEF)
OTCMKTS · Delayed Price · Currency is USD
113.13
+9.63 (9.30%)
At close: Jun 9, 2025
Ipsen Revenue
In the year 2025, Ipsen had annual revenue of 3.93B EUR with 9.92% growth. Ipsen had revenue of 1.99B in the half year ending December 31, 2025.
Revenue
3.93B EUR
Revenue Growth
+9.92%
P/S Ratio
3.18
Revenue / Employee
709.88K EUR
Employees
5,535
Market Cap
14.67B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.93B | 354.70M | 9.92% |
| Dec 31, 2024 | 3.57B | 268.10M | 8.11% |
| Dec 31, 2023 | 3.31B | 150.00M | 4.75% |
| Dec 31, 2022 | 3.16B | 407.80M | 14.84% |
| Dec 31, 2021 | 2.75B | 62.40M | 2.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 373.80M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 159.83M |
| Elite Pharmaceuticals | 140.12M |
| Earth Science Tech | 34.87M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
Ipsen News
- 21 hours ago - Ipsen Highlighted Early Immuno-Oncology Advances With New Data Presented At AACR - Nasdaq
- 5 days ago - Weekly Buzz: BMY Wins FDA Nod; EU Okays JNJ's AKEEGA; IPSEY Withdraws Tazverik, DAWN Acquired - Nasdaq
- 9 days ago - ORIC Pharmaceuticals Shares Drop Following Ipsen's Drug Withdrawal - GuruFocus
- 9 days ago - Ipsen Withdraws Tazverik Following Safety Concerns In SYMPHONY-1 Trial - Nasdaq
- 12 days ago - EMA Panel Backs Moderna's COVID-Flu Shot, Sanofi's Sleeping Sickness Drug, Ipsen's Cancer Drug - Nasdaq
- 27 days ago - Ipsen S.A. publishes its 2025 Consolidated Financial Statements - GlobeNewsWire
- 4 weeks ago - Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Ipsen S.A. (IPSEY) Q3 2025 Earnings Call Transcript - Seeking Alpha